Led $100M+ Data & AI partnerships at IBM and GitLab, spanning enterprise AI platforms, strategic alliances, and commercialization. Published trustworthy-AI and high-performance computing researcher.
BJ writes about the gap between the care a physician orders and the care that actually happens.
Deciding on a treatment isn't the same as the patient receiving it. Labs, authorizations, pharmacy, scheduling and follow-up sit in between, and the physician keeps the list of what's still open.
An insurer won't join a shared tool, and neither will a contracted group or a practice that just changed owners. So verification has to work by observation: a result lands, a note appears, a call comes back.
A model reading a chart can surface a plan with no result. It cannot surface the consult sent to a group that charts elsewhere, or the records request that went out by fax.
clinicians asked how they track what they're waiting on, since April
Not one physician named the EHR. Paper and memory win because they are the only tools that go wherever the work goes.
“I do it by paper and pen.”
Internal medicine attending on a teaching service
Why he co-founded Semblance
“We've spent our careers building high-stakes AI systems and delivering complex neurological care. We created Semblance to make sure clinical intent survives every handoff—until the work is done.”
Semblance founding team
BJ co-founded Semblance with Chris R. Collins, MD, MSCS, CRND, a Vanderbilt-, Ochsner- and Jefferson-trained neurologist who practiced at Penn State and Geisinger. Chris brings the clinic. BJ brings years of building enterprise AI and the partnerships around it.
If you run a specialty practice where treatment decisions wait on labs, authorizations and scheduling, give us twenty minutes. We'll trace the last patient who waited, from your decision to the first dose. You keep the write-up either way.
We're selecting a small number of specialty practices to work with before anything goes live.
